The AACR Board of Directors consists of world-renowned leaders in all areas of cancer research. The following five individuals have been elected to the AACR Board of Directors for the 2024-2027 term:
Manuel Hidalgo, MD, PhD, is chief of the Division of Hematology and Medical Oncology and Walter B. Wriston Professor of Pancreatic Cancer Research, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, New York. He is also associate director for clinical services at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and an attending physician at NewYork-Presbyterian/Weill Cornell Medical Center.
Electra D. Paskett, PhD, is founding director of the Center for Cancer Health Equity and deputy director of population sciences and community outreach at The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio. She is also the Marion N. Rowley Professor of Cancer Research and director of the Division of Cancer Prevention and Control at The Ohio State University College of Medicine. [
Katerina A. Politi, PhD, is a professor of pathology and internal medicine; coleader, Cancer Signaling Networks Research Program; scientific director, Center for Thoracic Cancers; codirector, Yale SPORE in Lung Cancer; and member, Yale Stem Cell Center, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
Jean-Charles Soria, MD, PhD, is the senior vice president, Global Oncology Development at Amgen in Thousand Oaks, California.
Catherine J. Wu, MD, FAACR, is chief of the Division of Stem Cell Transplantation and Cellular Therapies, Lavine Family Chair for Preventative Cancer Therapies, and a physician at Dana-Farber Cancer Institute; professor of medicine at Harvard Medical School; and institute member, Broad Institute of MIT and Harvard, Boston, Massachusetts.